Biotech · Private company
HUYABIO International, LLC.
Track this companyFree. Adds HUYABIO International, LLC. to your Dealase workspace and tells you when its record changes.
Clinical trials74 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- HBI-8000 in combination with nivolumabPhase 3 · Unresectable or Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- HBI-3000Phase 2 · Atrial FibrillationClinicalTrials.gov · fetched Nov 12, 2026
- HBI-8000 in combination with nivolumabPhase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- HBI-8000 in combination with pembrolizumabPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- HBI-2376Phase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- HBI-2438Phase 1 · Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- HBI-3000Phase 1 · Drug-drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
- ParoxetinePhase 1 · Drug-drug InteractionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C MutationPHASE1 · ACTIVE_NOT_RECRUITING · started Aug 1, 2022ClinicalTrials.gov NCT05485974 · fetched Nov 12, 2026
- A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung CancerPHASE2 · TERMINATED · started Feb 15, 2022ClinicalTrials.gov NCT05141357 · fetched Nov 12, 2026
- A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR MutationsPHASE1 · ACTIVE_NOT_RECRUITING · started Dec 13, 2021ClinicalTrials.gov NCT05163028 · fetched Nov 12, 2026
- Study Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced MelanomaPHASE3 · ACTIVE_NOT_RECRUITING · started Aug 12, 2021ClinicalTrials.gov NCT04674683 · fetched Nov 12, 2026
- A Study of IV HBI-3000 for the Conversion Recent Onset Atrial Fibrillation (AF)PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 1, 2021ClinicalTrials.gov NCT04680026 · fetched Nov 12, 2026
- Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female SubjectsPHASE1 · COMPLETED · started Feb 21, 2021ClinicalTrials.gov NCT04650542 · fetched Nov 12, 2026
- Study of HBI-8000 With Nivolumab in Melanoma, Renal Cell Carcinoma and Non-Small Cell Lung CancerPHASE1_PHASE2 · COMPLETED · started Aug 18, 2016ClinicalTrials.gov NCT02718066 · fetched Nov 12, 2026